Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -38.72% | -30.00% | -11.43% | -25.38% | 30.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.77% | -34.77% | -8.09% | -22.07% | 36.13% |
| Operating Income | 26.77% | 34.77% | 8.09% | 22.07% | -36.13% |
| Income Before Tax | 29.47% | 34.90% | 10.54% | 22.31% | -35.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.47% | 34.90% | 10.54% | 22.31% | -35.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.47% | 34.90% | 10.54% | 22.31% | -35.73% |
| EBIT | 26.77% | 34.77% | 8.09% | 22.07% | -36.13% |
| EBITDA | 26.82% | 35.08% | 8.27% | 22.36% | -36.00% |
| EPS Basic | 57.18% | 49.70% | 20.64% | 28.44% | -35.75% |
| Normalized Basic EPS | 57.17% | 49.69% | 20.65% | 28.56% | -35.69% |
| EPS Diluted | 57.18% | 49.70% | 20.64% | 28.44% | -35.75% |
| Normalized Diluted EPS | 57.17% | 49.69% | 20.65% | 28.56% | -35.69% |
| Average Basic Shares Outstanding | 64.70% | 29.41% | 12.73% | 8.57% | 0.00% |
| Average Diluted Shares Outstanding | 64.70% | 29.41% | 12.73% | 8.57% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |